3,0
15. Nov. 2014
Aktueller Mitarbeiter, mehr als 8 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Collaborative environment. People-focused. Bright and dedicated colleagues.
Kontras
conservative, risk averse. Company is trying to diversify the risks of developing pharmaceutical products that require high drug price to recoup the investment. After all, all major countries will eventually follow UK model.